There are more heart attacks on Christmas than any other day of the year
Medical Xpress - Cardiology
DECEMBER 19, 2024
We sing about how Christmas brings "tidings of comfort and joy," but the holiday also brings something not so "merry and bright.
Thu.Dec 19, 2024
103 
Tirzepatide Officially Off FDA's Shortage List
Med Page Today
DECEMBER 19, 2024
(MedPage Today) -- The shortage of the diabetes and obesity injectable tirzepatide (Mounjaro, Zepbound) has been resolved, the FDA announced Thursday. As a result, compounders will have a grace period of 60 to 90 days to wrap up production and.
Traffic noise and poverty create a dangerous cocktail for heart health
Medical Xpress - Cardiology
DECEMBER 19, 2024
A new study by the German Center for Cardiovascular Research (DZHK) shows that people on low incomes who are also exposed to high levels of traffic noise have a significantly increased risk of serious cardiovascular disease. The findings highlight the need to tackle social inequalities and environmental pollution together to improve the health of disadvantaged populations.
Scientists make surprising discovery pinpointing when good cholesterol becomes harmful
Science Daily - Heart Disease
DECEMBER 19, 2024
Researchers have discovered that certain components of so-called 'good' cholesterol -- high-density lipoproteins (HDL) -- may be associated with an increased prevalence of cardiovascular disease.
Surprising discovery pinpoints when good cholesterol becomes harmful
Medical Xpress - Cardiology
DECEMBER 19, 2024
Houston Methodist researchers have discovered that certain components of so-called "good" cholesterolhigh-density lipoproteins (HDL)may be associated with an increased prevalence of cardiovascular disease.
Late onset of biliobronchial fistula — a serious complication of hemihepatectomy for atrophic liver with hepatolithiasis: a case report and review of the literature
Journal of Cardiothoracic Surgery
DECEMBER 19, 2024
Acquired bronchobiliary fistula (BBF) is a rare but life-threatening complication that can occur as a result of oncological processes, inflammatory reactions, parasite infections, thoracoabdominal trauma, or i.
Research suggests coffee may protect against cognitive decline in people with atrial fibrillation
Medical Xpress - Cardiology
DECEMBER 19, 2024
Drinking multiple cups of coffee a day may help prevent cognitive decline in people with atrial fibrillation (AFib or AF), according to new research published in the Journal of the American Heart Association.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Largest study to date shows 39 weeks best for hypertensive pregnancies
Medical Xpress - Cardiology
DECEMBER 19, 2024
A collaborative study from physician researchers at the University of Cincinnati College of Medicine is shining new light on current guidelines for delivery timing in pregnant mothers with chronic hypertension.
The predictive value of monocyte count to high-density lipoprotein cholesterol ratio combined with left atrial diameter for post-radiofrequency ablation recurrence of paroxysmal atrial fibrillation in patients
Journal of Cardiothoracic Surgery
DECEMBER 19, 2024
Paroxysmal atrial fibrillation (PAF) usually recurs after radiofrequency ablation (RFA). This study probed the predictive value of monocyte count to high-density lipoprotein cholesterol (HDL-C) ratio (MHR) wit.
Risk for cardiovascular conditions increased with anorexia nervosa diagnosis
Medical Xpress - Cardiology
DECEMBER 19, 2024
Patients with an anorexia nervosa (AN) diagnosis have an increased risk for cardiovascular conditions, according to a study published online Dec. 19 in JAMA Network Open.
Olezarsen Earns First-Ever FDA Approval for Familial Chylomicronemia Syndrome
HCPLive
DECEMBER 19, 2024
Olezarsen ushers in a new era of care as the first therapy to receive FDA approval for adults with familial chylomicronemia syndrome as an adjunct to diet.
Reducing dose of popular blood thinners may limit risk of future bleeding, study finds
Medical Xpress - Cardiology
DECEMBER 19, 2024
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
Psoriasis Study Identifies Strategies for Enrolling More Patients with Skin of Color
HCPLive
DECEMBER 19, 2024
The VISIBLE studys findings indicate that specific strategies may yield more diverse populations in clinical trials for patients with psoriasis and other conditions.
Fluctuating Blood Pressure Tied to Problems with Thinking Skills
DAIC
DECEMBER 19, 2024
tim.hodson Thu, 12/19/2024 - 10:36 Dec. 11, 2024 Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the Dec. 11, 2024, online issue of Neurology , the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.
Less pain, quicker recoveries: 1 year of University Hospitals' robotics push
Becker's Hospital Review - Cardiology
DECEMBER 19, 2024
In one year since the inception of its robotics program, Cleveland-based University Hospitals' Harrington Heart & Vascular Institute has performed more than 100 heart bypass surgeries using the Da Vinci surgical robot.
Christine Frissora, MD: Vibrant System’s Role in Chronic Idiopathic Constipation Care
HCPLive
DECEMBER 19, 2024
Frissora reviews findings from a cost-effectiveness analysis comparing the Vibrant System to linaclotide for CIC management.
RWJUH to establish fellowship for 'underdiagnosed' condition
Becker's Hospital Review - Cardiology
DECEMBER 19, 2024
New Brunswick, N.J.-based Rutgers University's Robert Wood Johnson Medical School will establish a new cardiac specialty fellowship at the Robert Wood Johnson University Hospital with $80,000 from Pfizer.
Brexpiprazole with Sertraline Significantly Reduces PTSD Symptoms in 10 Days
HCPLive
DECEMBER 19, 2024
A phase 3 trial shows promising data for brexpiprazole with sertraline for PTSD symptoms ahead of the supplemental new drug applications PDUFA date in February 2024.
Vanderbilt pediatric cardiology chief stepping down
Becker's Hospital Review - Cardiology
DECEMBER 19, 2024
Scott Baldwin, MD, will step down as chief of the division of pediatric cardiology and co-director of the Pediatric Heart Institute at Monroe Carell Jr. Children's Hospital at Nashville, Tenn.-based Vanderbilt University.
U.S. Deaths Are Down and Life Expectancy Is Up, but Improvements Are Slowing
Med Page Today
DECEMBER 19, 2024
(MedPage Today) -- U.S. life expectancy jumped last year, and preliminary data suggest there may be another -- much smaller -- improvement this year. Death rates fell last year for almost all leading causes, notably COVID-19, heart disease.
LIB Therapeutics Submits BLA for Lerodalcibep Targeting Reductions in LDL-C
HCPLive
DECEMBER 19, 2024
Submission of the Biologics License Application seeks approval of lerodalcibep to lower LDL-C in patients with or at risk for ASCVD and primary hyperlipidemia.
Congress Seeks Streamlined Continuing Resolution, ACC Advocacy Urges Lawmakers to Address Health Policy Priorities
American College of Cardiology
DECEMBER 19, 2024
Congress must pass funding legislation by Dec. 20 to prevent a government shutdown. Although a continuing resolution (CR) proposed earlier this week included several important health care provisions, significant opposition due to the inclusion of many other policy add-ons have forced congressional leaders to pivot to developing a more streamlined CR.
Colchicine Prophylaxis for Gout Flares Linked to Lower Cardiovascular Events
HCPLive
DECEMBER 19, 2024
These findings, from an observational study, should be confirmed in a randomized, controlled trial.
A rapid deployment valve option for failing Medtronic Freestyle full root: a single centre experience
Journal of Cardiothoracic Surgery
DECEMBER 19, 2024
There are several high-risk treatment options for valve failure of a biological full root replacement. When tailoring the best treatment option for the patient, implantation of a rapid deployment valve (RDV) s.
Study Highlights Interim Results on Abrocitinib for Adolescents, Adults with Atopic Dermatitis
HCPLive
DECEMBER 19, 2024
These interim data resulted from the JADE REAL study, with 72-week results suggesting rapid improvements in eczema severity for adults and adolescents.
Aortic pressures within a giant right coronary artery aneurysm
Journal of Cardiothoracic Surgery
DECEMBER 19, 2024
Giant coronary artery aneurysms are rare conditions with potentially devastating consequences. We report a case of the largest documented giant right coronary artery (RCA) aneurysm to date.
Delta Corticomedullary Apparent Diffusion Coefficient Aids IgAN Risk Stratification
HCPLive
DECEMBER 19, 2024
Study findings suggest the potential utility of ADC for assisting the clinical, pathological, and prognostic risk stratification of patients with IgAN.
January 2025 Stroke Highlights
Stroke Journal
DECEMBER 19, 2024
Stroke, Volume 56, Issue 1 , Page 4-4, January 1, 2025.
Pathways to Precision Medicine in Hypertrophic Cardiomyopathy: Opportunities and Challenges in Plasma Proteomics
Circulation: Heart Failure
DECEMBER 19, 2024
Circulation: Heart Failure, Ahead of Print.
Editors and Editorial Board
Stroke Journal
DECEMBER 19, 2024
Stroke, Volume 56, Issue 1 , Page 1-3, January 1, 2025.
For IBD, No Cardiovascular Risk Difference Between JAK, TNF Inhibitors
Med Page Today
DECEMBER 19, 2024
(MedPage Today) -- ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, according to a retrospective single.
Correction to: Cardiac Contributions to Brain Health: A Scientific Statement From the American Heart Association
Stroke Journal
DECEMBER 19, 2024
Stroke, Volume 56, Issue 1 , Page e39-e39, January 1, 2025.
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0
HCPLive
DECEMBER 19, 2024
Yehuda Handelsman, MD highlights insulin resistances role in cardiometabolic disease and introduces DCRM 2.0 as a global, multi-specialty care framework.
Nonsurgical Management of Chronic Venous Insufficiency
American College of Cardiology
DECEMBER 19, 2024
The following are key points to remember from a review on nonsurgical management of chronic venous insufficiency (CVI).
Cardio‐ocular syndrome: Retinal microvascular changes in acutely decompensated heart failure
European Journal of Heart Failure
DECEMBER 19, 2024
Summary of the key background and findings of the study. ADHF, acute decompensated heart failure; IV, intravenous; IVC, inferior vena cava; NT-proBNP, N-terminal pro-B-type natriuretic peptide; OCT, optical coherence tomography; OCT-A, optical coherence tomography angiography. Abstract Aims To investigate the changes in retinal microvasculature by contemporary imaging techniques during episodes of acute decompensated heart failure (ADHF) and following recompensation compared to age-matched contr
Transcatheter Valve and Vessels
American College of Cardiology
DECEMBER 19, 2024
The goal of the TCW trial was to test the noninferiority and, if positive, superiority, of percutaneous coronary intervention (PCI) with transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) and coronary artery bypass grafting (CABG) in severe aortic stenosis (AS) with comorbid coronary artery disease (CAD).
Nurse-Led Multicomponent Behavioral Activation Intervention for Patients With Atrial Fibrillation: A Randomized Controlled Trial
Circulation: Arrhythmia and Electrophysiology
DECEMBER 19, 2024
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Patients with atrial fibrillation (AF) are often ill-equipped for shared decision-making. This study investigated the effects of a patient empowerment care model on patient-reported health outcomes and treatment decision-making in patients with AF.METHODS:This randomized controlled trial prospectively randomized patients with AF to receive standard care (n=194) or a 13-week nurse-led multicomponent behavioral activation in
Let's personalize your content